id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-2880-0004,FDA,FDA-2016-N-2880,"Microbiology Devices; Reclassification of Cytomegalovirus Doxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management, To Be Renamed Quantitative Cytomegalovirus Nucleic Acid Tests for Transplant Patient Management",Proposed Rule,Request for Comment,2020-09-18T04:00:00Z,2020,9,2020-09-18T04:00:00Z,2020-11-18T04:59:59Z,2020-11-18T02:01:34Z,2020-20716,0,0,090000648486493f